GM-CSF R alpha产品信息
英文名称:Granulocyte-macrophage colony-stimulating factor receptor subunit alpha
中文名称:粒细胞-巨噬细胞集落刺激因子受体α亚基
靶点别称:GM-CSF R alpha,GM-CSF-R-alpha,GMCSFR-alpha,GMR-alpha,CSF2RA,CSF2R,CSF2RY,CDw116,CD116
物种:Human/Mouse
属性:Protein
标记:Unconjugated
内毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
纯度(Purity)
>95% as determined by SDS-PAGE.
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
GM-CSF R alpha分子背景
GM-CSF Rα(粒细胞-巨噬细胞集落刺激因子受体亚基α)也称为CSF2RA、CD116、GMRα。粒细胞-巨噬细胞集落刺激因子低亲和力受体。传递导致造血细胞增殖、分化和功能激活的信号。遗传性肺泡蛋白沉积症(hPAP)是一种罕见的肺表面活性物质积聚和低氧性呼吸衰竭疾病,由CSF2RA(编码粒细胞/巨噬细胞集落刺激因子[GM-CSF]受体α链[CD116])突变引起,导致肺泡巨噬细胞对GM-CSF依赖性肺表面活性物质的清除减少。
关键字: GM-CSF R alpha;GM-CSF R alpha蛋白;GMCSFRA蛋白;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。